PROCEPT BioRobotics (PRCT) Asset Writedowns and Impairment (2020 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly Asset Writedowns and Impairment came in at $432000.0 in Q2 2026, down 24.21% year-over-year from $570000.0 in Q2 2025, and up 57.66% quarter-over-quarter from $274000.0 in Q1 2026.
Powered by 
Analysis
PROCEPT BioRobotics (PRCT) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Asset Writedowns and Impairment for 7 consecutive years, with $432000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 24.21% year-over-year to $432000.0 in Q2 2026; TTM through Jun 2026 was $371000.0, a 80.22% decrease from a year earlier, with the FY2025 full-year figure at $565000.0, down 69.96% from the prior year.
- Asset Writedowns and Impairment was $432000.0 for Q2 2026 at PROCEPT BioRobotics, up from $274000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $905000.0 in Q2 2024 and troughed at -$861000.0 in Q4 2025.
- A 5-year average of $300642.9 and a median of $353000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment jumped 567.82% in 2023 and plunged 243.5% in 2025, its largest moves.
- Over 5 years, Asset Writedowns and Impairment stood at -$25000.0 in 2022, then surged by 2424.0% to $581000.0 in 2023, then rose by 3.27% to $600000.0 in 2024, then sank by 243.5% to -$861000.0 in 2025, then jumped by 150.17% to $432000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $432000.0 (Q2 2026), $274000.0 (Q1 2026), and -$861000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 432,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | -861,000.00 |
| Sep 30, 2025 | 526,000.00 |
| Jun 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Jun 30, 2024 | 905,000.00 |
| Sep 30, 2023 | 581,000.00 |
| Jun 30, 2023 | 186,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Dec 31, 2022 | -25,000.00 |
| Sep 30, 2022 | 87,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2020 | 87,000.00 |